Gilead's twiceyearly shot cut HIV infections by 96% in trialhttps://www.cnbc.com/2024/09/12/gilead-lenacapavir-cut-hiv-infections-by-96percent-in-trial.html by jackallis • 2 years ago 4 0 2 years agoCNcnbc.com